Midazolam

🧬 Introduction

Midazolam Injection

Midazolam is a short-acting benzodiazepine used for sedation, anesthesia induction, seizure control, and ICU sedation. Its rapid onset and short duration make it ideal for acute interventions.

History

Synthesized in 1976 by Walser and Fryer at Hoffmann-LaRoche, Inc in the United States. The anticonvulsant properties of Midazolam were studied in the late 1970s, but not until the 1990s did it emerge as an effective treatment for convulsive status epilepticus.

🧪 Chemical Structure and Classification

  • Class: Benzodiazepine derivativeMidazolam Chemical Structure
  • IUPAC Name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
  • Molecular Formula: C₁₈H₁₃ClFN₃
  • Molecular Weight: 325.77 g/mol
  • Unique Feature: Imidazole ring → water-soluble at acidic pH, lipid-soluble at physiological pH.

 

Formulation

  • As injectable form, it is a clear colourless solution containing either 1mg, 2mg, or 5mg per ml
  • Also available as tablet and as nasal preparation for paediatric use
  • Administration by PO, IM, IV, buccal or intranasal routes

Diluents: Normal Saline, 5% Dextrose or Sterile Water

⚙️ Mechanism of Action

Midazolam binds to the benzodiazepine site on the GABA(_A) receptor, enhancing GABA’s inhibitory effect.

  • ↑ Frequency of chloride channel opening
  • Neuronal hyperpolarization → CNS depression
  • Produces sedation, anxiolysis, amnesia, anticonvulsant effects

📈 Pharmacokinetics

  • Absorption: Rapid IV; variable oral due to first-pass metabolism
  • Distribution: Lipophilic at physiological pH → rapid CNS penetration
  • Metabolism: Hepatic via CYP3A4 → active metabolite (1-hydroxymidazolam)
  • Elimination: Renal excretion
  • Half-life: 1.5–3 h (longer in elderly/critically ill)

🔬 Pharmacodynamics

  • Onset: IV 1–5 min; IM 15 min; Oral 15–30 min
  • Peak Effect: IV 3–5 min
  • Duration: IV 30–60 min (dose-dependent)
  • Effects: Sedation, anxiolysis, amnesia, anticonvulsant activity, mild muscle relaxation
  • Dose–Response: Steep curve — small dose changes can cause large sedation differences

🩺 Clinical Uses

  • Procedural sedation (endoscopy, bronchoscopy)
  • Anesthesia induction
  • ICU sedation (infusion)
  • Acute seizure control (including status epilepticus)
  • Premedication before surgery
  • Palliative care for refractory agitation

💉 Dosage and Administration

  • IV sedation: 0.02–0.07 mg/kg (titrate slowly)
  • Anesthesia induction: 0.1–0.3 mg/kg IV
  • Seizures: 0.2 mg/kg IV/IM/intranasal (max 10 mg)
  • Pediatrics: Weight-based; avoid benzyl alcohol in neonates

⚠️ Adverse Effects

  • Respiratory depression
  • Hypotension
  • Paradoxical agitation (rare)
  • Anterograde amnesia
  • Prolonged sedation in organ impairment

🚫 Contraindications and Precautions

  • Hypersensitivity to benzodiazepines
  • Acute narrow-angle glaucoma
  • Severe respiratory depression without ventilatory support
  • Caution in elderly, debilitated, organ-impaired patients

🔄 Drug Interactions

  • CYP3A4 inhibitors → prolonged sedation
  • CYP3A4 inducers → reduced effect
  • Additive CNS depression with opioids, alcohol, antihistamines

👶 Special Considerations

  • Neonates: Immature metabolism → prolonged sedation
  • Elderly: Increased sensitivity → lower doses
  • Obese: Larger Vd → prolonged elimination
  • Critically ill: Altered PK due to organ dysfunction

📝 Conclusion

Midazolam is a cornerstone sedative with rapid onset and short duration, but requires careful titration and monitoring due to its narrow safety margin.

💬 Frequently Asked Questions (FAQ)

1. What is Midazolam?

Midazolam is a short-acting benzodiazepine used for sedation, anesthesia induction, seizure control, and ICU sedation. It works by enhancing the effect of GABA at the GABA_A receptor, leading to CNS depression.

 

📋 Midazolam – Quick Reference FAQ Table

Question Key Answer
What is Midazolam? Short‑acting benzodiazepine; enhances GABA(_A) receptor activity → CNS depression.
Main Uses Procedural sedation, anesthesia induction, seizure control, ICU sedation, pre‑op medication.
Routes of Administration IV, IM, oral, intranasal, rectal.
Onset & Duration IV onset: 1–5 min; duration: 30–60 min (dose‑dependent).
Common Side Effects Drowsiness, dizziness, nausea, amnesia, respiratory depression.
Serious Risks Respiratory arrest, hypotension, paradoxical agitation, allergic reactions (rare).
Contraindications Benzodiazepine allergy, acute narrow‑angle glaucoma, severe respiratory depression without support.
Drug Interactions CYP3A4 inhibitors ↑ effect; CYP3A4 inducers ↓ effect; additive CNS depression with opioids/alcohol.
Use in Children Yes, weight‑based dosing; neonates have prolonged sedation risk.
Pregnancy/Breastfeeding Use only if benefits outweigh risks; may cause neonatal respiratory depression; small amounts in breast milk.

 

Comments are closed.